{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:24:00Z","timestamp":1787207040678,"version":"build-2736575974"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide, necessitating the development of safer and more targeted therapeutic strategies. This study computationally extends our previous experimental investigation of a peptide derived from\n                      <jats:italic>Lacticaseibacillus casei<\/jats:italic>\n                      by evaluating its interactions with two clinically relevant breast cancer targets, estrogen receptor alpha (ER\u03b1; PDB ID: 3ERT) and human epidermal growth factor receptor 2 (HER2; PDB ID: 1N8Z).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The peptide structure was predicted using PEP-FOLD and its stereochemical quality was assessed using a Ramachandran plot. Molecular docking was performed against ER\u03b1 and HER2, followed by molecular dynamics simulations to evaluate structural stability. Binding free energy, binding affinity, dissociation constant, principal component analysis (PCA), free energy landscape (FEL), molecular mechanics (MM)\/Poisson\u2013Boltzmann surface area (PBSA) calculations, and\n                      <jats:italic>in silico<\/jats:italic>\n                      ADMET and toxicity predictions were performed to comprehensively characterise peptide\u2013protein interactions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The predicted peptide model exhibited 84.8% of residues located in the most favoured regions, while 15.2% were located in additionally allowed regions of the Ramachandran plot, indicating satisfactory stereochemical quality. Molecular docking demonstrated favourable interactions with both ER\u03b1 and HER2, with HER2 showing a marginally more favourable docking score. Molecular dynamics simulations indicated stable peptide\u2013protein complexes throughout the simulation period, as supported by root mean square deviation (RMSD), root mean square fluctuation (RMSF), radius of gyration (Rg), solvent-accessible surface area (SASA), and hydrogen-bond analyses. MM\/PBSA calculations predicted stronger binding for the HER2 (1N8Z) complex (\u0394G = \u221228.83 kJ\/mol) than for the ER\u03b1 (3ERT) complex (\u0394G = \u221211.65 kJ\/mol), highlighting the complementary nature of docking and dynamic free-energy estimation, which produced different receptor rankings. PCA and FEL analyses further demonstrated stable conformational sampling for both complexes. ADMET predictions suggested favourable peptide-like physicochemical properties while identifying pharmacokinetic and toxicity parameters that require further experimental validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This computational study suggests that the\n                      <jats:italic>L. casei<\/jats:italic>\n                      -derived peptide exhibits favourable predicted interactions with ER\u03b1 and HER2 and forms structurally stable peptide\u2013protein complexes under simulated physiological conditions. These findings provide a computational framework for prioritising this probiotic-derived peptide for subsequent experimental validation and further investigation as a potential peptide-based therapeutic candidate for breast cancer.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fbinf.2026.1918460","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:28:59Z","timestamp":1787203739000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational blueprint and stereochemical validation of a small peptide derived from Lacticaseibacillus casei VITCM05 targeting estrogen receptor alpha and human epidermal growth factor receptor 2"],"prefix":"10.3389","volume":"6","author":[{"given":"G. R.","family":"Shree Kumari","sequence":"first","affiliation":[{"name":"School of Bio Sciences and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanasrinivasan","family":"Vaithilingam","sequence":"additional","affiliation":[{"name":"School of Bio Sciences and Technology, Vellore Institute of Technology","place":["Vellore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"Bateman","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB protein data bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins \u2014 a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"128325","DOI":"10.1016\/j.ijbiomac.2023.128325","article-title":"Ribosomally synthesized bacteriocins of lactic acid bacteria: simplicity yet having wide potentials \u2013 a review","volume":"256","author":"Daba","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"B6","first-page":"193","volume-title":"Principal Component Analysis: A Method for Determining the Essential Dynamics of Proteins","author":"David","year":"2014"},{"key":"B7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong","year":"2018","journal-title":"J. Cheminform."},{"key":"B8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"B9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1310443","DOI":"10.3389\/fimmu.2024.1310443","article-title":"Bioactive peptides: an alternative therapeutic approach for cancer management","volume":"15","author":"Ghadiri","year":"2024","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancers","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B12","doi-asserted-by":"publisher","first-page":"114060","DOI":"10.1016\/j.foodres.2024.114060","article-title":"Food peptidomic analysis of bovine milk fermented by Lacticaseibacillus casei LBC 237: in silico prediction of bioactive peptides and anticancer potential","volume":"180","author":"Hiago Bellaver","year":"2024","journal-title":"Food Res. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","article-title":"Molecular dynamics simulation for all","volume":"99","author":"Hollingsworth","year":"2018","journal-title":"Neuron"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.7324\/JABB.2022.100206","article-title":"Partial identification of a peptide from Lacticaseibacillus casei using MALDI TOF and it\u2019s cytotoxic activity against MDA-MB-231 cell line","volume":"11","author":"Jannatul Firdous","year":"2022","journal-title":"J. Appl. Biol. Biotechnol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fphar.2015.00272","article-title":"Bacteriocins as potential anticancer agents","volume":"6","author":"Kaur","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12860-023-00484-3","article-title":"A computational peptide model induces cancer cells\u2019 apoptosis by docking kringle 5 to GRP78","volume":"24","author":"Khater","year":"2023","journal-title":"BMC Mol. Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"B21","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.33011\/livecoms.1.1.5068","article-title":"From proteins to perturbed hamiltonians: a suite of tutorials for the GROMACS-2018 molecular simulation package [article v1.0]","volume":"1","author":"Lemkul","year":"2018","journal-title":"Living J. comput. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jmb.2008.10.018","article-title":"Principal component analysis for protein folding dynamics","volume":"385","author":"Maisuradze","year":"2009","journal-title":"J. Mol. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e37054","DOI":"10.1016\/j.heliyon.2024.e37054","article-title":"Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health","volume":"10","author":"Niamah","year":"2024","journal-title":"Heliyon"},{"key":"B27","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s44345-025-00023-x","article-title":"Anticancer efficacy of Artiodactyla milk peptides targeting MCL-1 and ER\u03b1 receptors in breast cancer: insights from in-silico screening and molecular dynamics studies","volume":"2","author":"Pratik","year":"2025","journal-title":"Discov. Mol."},{"key":"B29","unstructured":"ScientiFlow: fully automated scientific workflow automation tool\n          \n          \n          2025"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1080\/07391102.2024.2314748","article-title":"In silico investigations and molecular insights for designing tRNA-encoded peptides as potential therapeutics for targeting over-expressed receptors in breast cancer","volume":"43","author":"Shanthappa","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7324\/JABB.2023.38024","article-title":"Extraction of a novel bacteriocin from Lacticaseibacillus casei VITCM05 and its antibacterial activity against major food-borne pathogens","volume":"10","author":"Siddique","year":"2022","journal-title":"J. Appl. Biol. Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"150901","DOI":"10.1063\/1.5049637","article-title":"Perspective: identification of collective variables and metastable states of protein dynamics","volume":"149","author":"Sittel","year":"2018","journal-title":"J. Chem. Phys."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"B34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"B36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2026.1918460\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:29:00Z","timestamp":1787203740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2026.1918460\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":38,"alternative-id":["10.3389\/fbinf.2026.1918460"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2026.1918460","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1918460"}}